Skip to main content

Sentinus, LLC

SEC CIK
0001811345
Latest filing
Aug 11, 2026

ATNM holding history

Actinium Pharmaceuticals, Inc. in every 13F filed by Sentinus, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ATNM overviewAll 13F holders of ATNMFull Q2 2026 holdings

Shares (Q2 2023)
167,275
Value
$1.24M
% of portfolio
0.4%
Quarters held
4
Since Q3 2022
Holdings of ATNM by Sentinus, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 2023––––Not filedHolders
Q2 2023167,275$1.24M0.4%+18,225+12.2%AddedHolders
Q1 2023149,050$1.41M0.5%+126,050+548.0%AddedHolders
Q4 202223,000$271.6K0.2%+500+2.2%AddedHolders
Q3 202222,500$166.0K0.1%–No prior filingHolders